BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 25398491)

  • 1. Role of IL-17 and IL-22 in autoimmunity and cancer.
    Blake SJ; Teng MW
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():41-50. PubMed ID: 25398491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease.
    Mitra A; Raychaudhuri SK; Raychaudhuri SP
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():21-33. PubMed ID: 25398489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the Th17 cytokines IL-17 and IL-22 in Rheumatoid Arthritis pathogenesis and developments in cytokine immunotherapy.
    Roeleveld DM; Koenders MI
    Cytokine; 2015 Jul; 74(1):101-7. PubMed ID: 25466295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting IL-17 in autoimmunity and inflammation.
    Kim BS; Park YJ; Chung Y
    Arch Pharm Res; 2016 Nov; 39(11):1537-1547. PubMed ID: 27576555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional specialization of interleukin-17 family members.
    Iwakura Y; Ishigame H; Saijo S; Nakae S
    Immunity; 2011 Feb; 34(2):149-62. PubMed ID: 21349428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy.
    Kramer JM; Gaffen SL
    J Periodontol; 2007 Jun; 78(6):1083-93. PubMed ID: 17539723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the role of interleukin-22 in neurological and autoimmune disorders.
    Xin N; Namaka MP; Dou C; Zhang Y
    Int Immunopharmacol; 2015 Oct; 28(2):1076-83. PubMed ID: 26311525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential.
    Zhu S; Qian Y
    Clin Sci (Lond); 2012 Jun; 122(11):487-511. PubMed ID: 22324470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic potential of targeting IL-17.
    Jones SA; Sutton CE; Cua D; Mills KH
    Nat Immunol; 2012 Nov; 13(11):1022-5. PubMed ID: 23080193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of a germline, IL-17-neutralizing antibody in murine models of autoimmune inflammatory disease.
    Dallenbach K; Maurer P; Röhn T; Zabel F; Kopf M; Bachmann MF
    Eur J Immunol; 2015 Apr; 45(4):1238-47. PubMed ID: 25545966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Th17 pathway as a therapeutic target in rheumatoid arthritis and other autoimmune and inflammatory disorders.
    Roeleveld DM; van Nieuwenhuijze AE; van den Berg WB; Koenders MI
    BioDrugs; 2013 Oct; 27(5):439-52. PubMed ID: 23620106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting Th17 Effector Cytokines for the Treatment of Autoimmune Diseases.
    Yamagata T; Skepner J; Yang J
    Arch Immunol Ther Exp (Warsz); 2015 Dec; 63(6):405-14. PubMed ID: 26358867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
    Yao X; Huang J; Zhong H; Shen N; Faggioni R; Fung M; Yao Y
    Pharmacol Ther; 2014 Feb; 141(2):125-39. PubMed ID: 24076269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-19, IL-20 and IL-24: potential therapeutic targets for autoimmune diseases.
    Leng RX; Pan HF; Tao JH; Ye DQ
    Expert Opin Ther Targets; 2011 Feb; 15(2):119-26. PubMed ID: 21073280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-22: a likely target for treatment of autoimmune diseases.
    Yang X; Zheng SG
    Autoimmun Rev; 2014 Jun; 13(6):615-20. PubMed ID: 24418299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 and innate immunity in infections and chronic inflammation.
    Isailovic N; Daigo K; Mantovani A; Selmi C
    J Autoimmun; 2015 Jun; 60():1-11. PubMed ID: 25998834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenic role of IL-17 in psoriasis and psoriatic arthritis.
    Chiricozzi A
    Actas Dermosifiliogr; 2014 Oct; 105 Suppl 1():9-20. PubMed ID: 25398488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting IL-23 in autoimmunity.
    Hölscher C
    Curr Opin Investig Drugs; 2005 May; 6(5):489-95. PubMed ID: 15912962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Th17 cells in autoimmune diseases.
    Yang J; Sundrud MS; Skepner J; Yamagata T
    Trends Pharmacol Sci; 2014 Oct; 35(10):493-500. PubMed ID: 25131183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.